Metformin, Hydrochloride, 500Mg, Tablet. The Packaging Must Contain Sales Prohibited By Commerce. Present The Product Registration With Anvisa And The Certificate Of Good Practices, Manufacturing And Control - Cbpfc From The Manufacturer In Accordance With Anvisa Resolution No. 460/99. In The Case Of The Manufacturer Outside Mercosul, Present The Document From The Country Of Origin Translated By An Official Translator. Rivaroxaban, 15Mg Coated Tablet. The Packaging Will Contain The Printing: Sale Prohibited By Commerce. Present Registration Of Products With Anvisa And Certificate Of Good Practices, Manufacturing And Control - Cbpfc Of The Manufacturer In Accordance With Anvisa Resolution No. 460/99. In The Case Of A Manufacturer Outside Mercosur, Rosuvastatin, Calcica 20Mg, Tablet. The Packaging Must Contain Commercially Prohibited Sales. Present Product Registration With Anvisa And Certificate Of Good Practices, Present Document From The Country Of Origin Translated By An Official Translator, Acid, Tranexamic 50Mg/Ml, Injectable, Ampoule With 5 Ml. The Packaging Must Display The Phrase: Sale Prohibited By Commerce. The Supplier Must Present Information Sheet, Product Registration With Anvisa And Certificate Of Good Manufacturing Practices - Cbpf In Compliance With Current Resolutions At Anvisa. In The Case Of The Manufacturer Outside Mercosur, Present A Document From The Country Of Origin Translated By An Official Translator. Supply Unit: Ampoule, Calcitonin, Synthetic Salmon 200Ui/Dose, Nasal Solution, Nebolizer Bottle, 2Ml (Minimum 14 Doses). The Packaging Must Display The Phrase: Sale Prohibited By Commerce. The Supplier Must Present A Leaflet And A Document From The Country Of Origin Translated By An Official Translator. Supply Unit: Nebolizer Bottle, 01/29/2026 - 18:30:03
We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.
